Sign In

Chana Greenberg

CEO Pharma C Investments

Professional Background

Chana Greenberg is an accomplished executive with a rich tapestry of experience in the finance and biopharmaceutical industries. As the Chief Executive Officer at Pharma C Investments, Chana leads a dynamic team driving investment and innovation in the pharmaceutical space. Her robust leadership is characterized by strategic vision and an unwavering commitment to advancing healthcare solutions.

Previously, Chana served as the Managing Director of ECP Biotherapeutics at EVRENSEL CAPITAL PARTNERS Ltd, where she was instrumental in shaping business strategy and fostering partnerships that enhance growth and operational efficiency. With a strong background in business development, she has held prominent positions in organizations such as Brains Bioceutical Corp., where she was the VP of Business Development, and advanacing initiatives at the Centre for Medicinal Cannabis as the Business Development Lead. Her roles have consistently revolved around the intersection of business strategy and healthcare innovation, showcasing her ability to navigate complex markets while delivering results.

Chana began her career in finance as an Analyst at Wolfson Investments, progressing through various roles, including Investment Banking Associate at Barclays Investment Bank. These foundational experiences laid the groundwork for her analytical skills and understanding of financial markets, preparing her for future leadership on the corporate side of the healthcare and investment sectors.

Education and Achievements

Chana Greenberg's educational journey is as impressive as her professional accomplishments. She earned her Bachelor’s Degree in Business Studies with a focus on Economics from the prestigious University of Westminster. This empowered her with a solid understanding of economic principles, business practices, and market dynamics. Chana further honed her knowledge in finance through the Master of Philosophy (MPhil) program at the University of Cambridge, where she was awarded a full Economic and Social Research Council (ESRC) scholarship, highlighting her academic excellence and research capabilities.

To deepen her expertise in private equity, she participated in an executive program at the renowned Saïd Business School at the University of Oxford, benefitting from a partial scholarship. This experience not only broadened her financial acumen but also expanded her professional network within one of the world's leading business universities.

Notable Achievements

Throughout her career, Chana Greenberg has been pivotal in driving growth and facilitating successful partnerships within the biopharmaceutical sector. Her strategic leadership at Pharma C Investments has led to several successful funding rounds and collaborations aimed at developing innovative therapies. She has been recognized for her exceptional ability to create value in organizations through effective business development strategies.

Her previous position as VP of Business Development at Brains Bioceutical Corp. saw her leading numerous initiatives that not only expanded market reach but also contributed significantly to the company’s pipeline of medicinal products. At the Centre for Medicinal Cannabis, she played a vital role in shaping and advocating for regulations that support cannabis as a legitimate therapeutic option, reflecting her commitment to advancing medical research and patient care.

As a former analyst and derivatives broker at Barclays Investment Bank, Chana developed critical insights and analytical skills essential for navigating the complexities of investment banking and capital markets. Her multifaceted experience positions her as a thought leader in the sectors she influences, contributing intelligently to discussions on investment strategies, market trends, and biopharmaceutical advancements.

Related Questions

How did Chana Greenberg prepare for her CEO role at Pharma C Investments?
What motivated Chana Greenberg to pursue a Master of Philosophy in Finance at the University of Cambridge?
How does Chana Greenberg apply her background in investment banking to her current position in biopharmaceuticals?
What key strategies has Chana Greenberg implemented at ECP Biotherapeutics that have contributed to its success?
In what ways does Chana Greenberg foresee the future evolution of the biopharmaceutical industry?
C
Add to my network

Location

London, England, United Kingdom